Efficacy and safety of desensitization protocol based on rituximab and tacrolimus in living donor kidney transplantation recipients with preformed anti-HLA antibodies and/or donor-specific antibodies: an open-label, single-arm, multicenter clinical study in Japan
Released on J-STAGE: February 03, 2026 |
Volume 60
Issue 3
Pages 165-181
Ken NAKAGAWA, Hideki OHDAN, Kenji YUZAWA, Takashi KENMOCHI, Shinichi NISHI, Ryoichi IMAMURA, Shigeru SATOH, Yasuhiro OKABE, Hideki ISHIDA, Yoshihiko WATARAI, Daiki IWAMI, Kazunobu SHINODA, Hiroshi HARADA, Hiroshi TANAKA, Kazuhide SAITO, Ichiro NAKAJIMA, Kunio MOROZUMI, Hiroki HASHIGUCHI, Yasuo OHASHI, Fujio MATSUO, Asako SAKAI, Izumi OKUGAITO, Hiroto EGAWA